News und Analysen
This Deep Value Stock Is a Strong Buy
Value investing can be a powerful strategy. Buying businesses for less than they are worth can limit your risk of significant capital losses, and it can increase your chances of future upside.
The
Exelixis (EXEL) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q2 2023 Earnings CallAug 01, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Pfizer (PFE) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2023 Earnings CallAug 01, 2023, 10:00 a.m. ET
Operator
Source Fool.com
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2023 Earnings CallAug 01, 2023, 4:30 p.m. ET
Operator
Source Fool.com
3 Magnificent High-Yield Dividend Stocks to Buy Hand Over Fist in August
Any time is a good time for income investors to buy dividend stocks. But certain times are better than others for specific stocks.
I think that's the case for several great picks with a new month
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Biogen's (NASDAQ: BIIB) biggest problem in recent times has been growth. The biotech giant's multiple sclerosis (MS) portfolio is facing more and more generic competition, and that's resulted in
Why Novavax Stock Zoomed 13% Higher on Monday
News of a fresh COVID-19 surge sent numerous stockholders into the shares of vaccine maker Novavax (NASDAQ: NVAX) on the first trading day of the week. As a result, Novavax's shares popped more than
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB) will soon likely be going head to head in the market for therapies that treat Alzheimer's disease. Both drug developers see the market for such
Could This Stock Be the Next Biotech Buyout?
Shares of Reata Pharmaceuticals (NASDAQ: RETA) recently jumped about 54% higher in a single trading session. This biotech stock was already way up this year thanks to the recent approval of its
These 2 Stocks Are Heading for a Big Moment. Time to Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) both are approaching a crucial moment in their stories. The biotech companies are awaiting regulatory decisions for
4 Top Stocks and 3 Top Cryptocurrencies for August
The stock market has rallied so far this year, particularly in the period between the last earnings season and this one. Companies now have to prove to Wall Street that their higher stock prices are
2 Healthcare Stocks That Could Make You Richer
Animal health company Zoetis (NYSE: ZTS) and pharmaceutical giant Eli Lilly (NYSE: LLY) are healthcare companies that are off to solid starts this year, with Zoetis' shares up more than 30% and
3 Stocks Retirees Should Absolutely Love
Dividend stocks can practically be a retiree's best friend. At least, the right ones can be. Three Motley Fool contributors were asked to identify healthcare dividend stocks they think retirees
Centene (CNC) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q2 2023 Earnings CallJul 28, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Why Shares of Genelux Climbed This Week
Shares of Genelux (NASDAQ: GNLX) were up 14.8% for the week, as of 9:30 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company's stock
Why UnitedHealth's Rising Medical Care Ratio Didn't Stop It From Beating Expectations in Q2
In June, UnitedHealth Group (NYSE: UNH) alerted investors that its costs were creeping up due to increasing demand for surgeries. That led to a decline in the share price heading into the company's
Is UnitedHealth Group Stock a Buy?
With a market cap of $472 billion and tens of millions of people covered under its plans, UnitedHealth Group (NYSE: UNH) is the undisputed king of health insurance stocks. But over the last 12
Best Beaten-Down Growth Stock to Buy: Nano Dimension vs. Invitae
Fool.com contributor Parkev Tatevosian compares Nano Dimension (NASDAQ: NNDM) and Invitae (NYSE: NVTA) across critical financial variables, including valuation, to determine the better stock to buy
DexCom (DXCM) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q2 2023 Earnings CallJul 27, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Why Novocure Stock Tumbled by Nearly 16% Today
Biotech stocks are famously volatile, and investors needed to look no further than the performance of Novocure's (NASDAQ: NVCR) shares on Thursday for proof. The company's share price cratered by
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
AbbVie (NYSE: ABBV)Q2 2023 Earnings CallJul 27, 2023, 9:00 a.m. ET
Liz Shea
Source Fool.com
Why Shares of Evolus Are Jumping Thursday
Shares of Evolus (NASDAQ: EOLS) were up more than 25% as of 11 a.m. ET after the company reported record quarterly revenue and increased guidance. The stock is up 31% so far this year.
Evolus is a
Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?
Even with government programs like Social Security, many people seek to save their own money for retirement, often setting the goal of reaching the $1 million mark by the time they reach retirement
Does Pfizer's Latest Biotech Move Make It a Buy?
On July 18, Pfizer (NYSE: PFE) announced that it is forging a strategic alliance with Flagship Pioneering, a venture capital (VC) firm, in which the pair would invest $50 million each into 10
2 Dirt Cheap Dividend Stocks to Buy Right Now
Equity markets can be volatile, erratic, and not always entirely rational. That sometimes results in shares of companies not being adequately priced. And when these stocks trade for less than